Company news

Ekso Bionics Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

March 27, 2023

Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

March 19, 2023

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

February 22, 2023

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

December 4, 2022

Ekso Bionics Reports Third Quarter 2022 Results

November 2, 2022

Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022

October 26, 2022

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

September 5, 2022

Ekso Bionics Reports Second Quarter 2022 Results

July 27, 2022

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

July 20, 2022

Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

June 12, 2022

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

May 25, 2022

Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference

May 16, 2022

Ekso Bionics Reports First Quarter 2022 Results

April 27, 2022

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

April 20, 2022

Ekso Bionics Reports Fourth Quarter and Year End 2021 Results

February 23, 2022

Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

February 16, 2022

Ekso Bionics Announces Leadership Transition

January 20, 2022

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

January 9, 2022

Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference

January 3, 2022

Ekso Bionics Appoints Corinna E. Lathan, Ph.D. to its Board of Directors

December 27, 2021

Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles

December 15, 2021

Ekso Bionics Reports Third Quarter 2021 Results

November 1, 2021

Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021

October 25, 2021

Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

September 6, 2021

Ekso Bionics Reports Second Quarter 2021 Results

July 28, 2021

Ekso Bionics to Report Second Quarter 2021 Financial Results on July 29, 2021

July 21, 2021

Ekso Bionics® Announces Expanded Partnership with Kindred Healthcare for Multi-Unit EksoNR Order

May 10, 2021

Ekso Bionics Reports First Quarter 2021 Results

April 28, 2021

Ekso Bionics to Report First Quarter 2021 Financial Results on April 29, 2021

April 21, 2021

Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR

March 8, 2021

Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology

March 2, 2021

Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference

March 1, 2021

Ekso Bionics Reports Fourth Quarter and Year End 2020 Results

February 24, 2021

Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

February 17, 2021

Ekso Bionics Announces Closing of $40 Million Bought Deal Offering

February 10, 2021

Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million

February 7, 2021

Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock

February 7, 2021

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results

January 12, 2021

Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference

January 4, 2021

Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors

December 29, 2020

Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company

November 9, 2020

Ekso Bionics Reports Third Quarter 2020 Results

October 28, 2020

Ekso Bionics Announces EGM Builders as First Customer to Adopt EVO Technology

October 28, 2020

Ekso Bionics® to Report Third Quarter 2020 Financial Results on October 29, 2020

October 21, 2020

Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020

September 8, 2020

Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use

August 19, 2020

Ekso Bionics Reports Second Quarter 2020 Results

July 29, 2020

Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020

July 22, 2020

Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial

July 8, 2020

Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients

June 24, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks